| Year |
Citation |
Score |
| 2023 |
Liu H, Liu M, Zhao Y, Mo R. Nanomedicine strategies to counteract cancer stemness and chemoresistance. Exploration of Targeted Anti-Tumor Therapy. 4: 630-656. PMID 37720349 DOI: 10.37349/etat.2023.00157 |
0.375 |
|
| 2022 |
Shen S, Li T, Fan J, Shao Q, Dong H, Xu X, Mo R. Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor. Acta Pharmaceutica Sinica. B. 13: 1262-1273. PMID 36970217 DOI: 10.1016/j.apsb.2022.11.009 |
0.492 |
|
| 2022 |
Wang Q, Chen C, Xu X, Shu C, Cao C, Wang Z, Fu Y, Xu L, Xu K, Xu J, Xia A, Wang B, Xu G, Zou X, Su R, ... ... Mo R, et al. APAF1-Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2201889. PMID 35975461 DOI: 10.1002/advs.202201889 |
0.373 |
|
| 2022 |
Shen S, Lin S, Chen Y, Zhang Y, He Y, Xu X, Feng Y, Lu Y, Mo R. Combating Cancer Stem-Like Cell-Derived Resistance to Anticancer Protein by Liposome-Mediated Acclimatization Strategy. Nano Letters. PMID 35254834 DOI: 10.1021/acs.nanolett.2c00004 |
0.42 |
|
| 2021 |
Jiang T, Ma Y, Xu X, Ji Q, Feng M, Cheng C, Feng Y, He B, Mo R. Enzyme-instructed hybrid nanogel/nanofiber oligopeptide hydrogel for localized protein delivery. Acta Pharmaceutica Sinica. B. 11: 2070-2079. PMID 34386339 DOI: 10.1016/j.apsb.2020.11.010 |
0.418 |
|
| 2021 |
Jiang T, Liu C, Xu X, He B, Mo R. Formation Mechanism and Biomedical Applications of Protease-Manipulated Peptide Assemblies. Frontiers in Bioengineering and Biotechnology. 9: 598050. PMID 33718335 DOI: 10.3389/fbioe.2021.598050 |
0.3 |
|
| 2021 |
Shen S, Xu X, Lin S, Zhang Y, Liu H, Zhang C, Mo R. A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells. Nature Nanotechnology. 16: 104-113. PMID 33437035 DOI: 10.1038/s41565-020-00793-0 |
0.445 |
|
| 2020 |
Xu X, Huang X, Zhang Y, Shen S, Feng Z, Dong H, Zhang C, Mo R. Self-regulated hirudin delivery for anticoagulant therapy. Science Advances. 6. PMID 33036973 DOI: 10.1126/sciadv.abc0382 |
0.393 |
|
| 2020 |
Dong H, Xu X, Wang L, Mo R. Advances in living cell-based anticancer therapeutics. Biomaterials Science. PMID 32254876 DOI: 10.1039/d0bm00036a |
0.497 |
|
| 2020 |
Wang H, Xu X, Guan X, Shen S, Huang X, Kai G, Zhao S, Ruan W, Zhang L, Pang T, Mo R. Liposomal 9-Aminoacridine for Treatment of Ischemic Stroke: From Drug Discovery to Drug Delivery. Nano Letters. PMID 32039606 DOI: 10.1021/acs.nanolett.9b04018 |
0.378 |
|
| 2019 |
Xu X, Li T, Shen S, Wang J, Abdou P, Gu Z, Mo R. Advances in Engineering Cells for Cancer Immunotherapy. Theranostics. 9: 7889-7905. PMID 31695806 DOI: 10.7150/Thno.38583 |
0.451 |
|
| 2019 |
Chen X, Zhu Q, Xu X, Shen S, Zhang Y, Mo R. Sequentially Site-Specific Delivery of Apoptotic Protein and Tumor-Suppressor Gene for Combination Cancer Therapy. Small (Weinheim An Der Bergstrasse, Germany). e1902998. PMID 31441204 DOI: 10.1002/smll.201902998 |
0.411 |
|
| 2019 |
Zhou Q, Shao S, Wang J, Xu C, Xiang J, Piao Y, Zhou Z, Yu Q, Tang J, Liu X, Gan Z, Mo R, Gu Z, Shen Y. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy. Nature Nanotechnology. PMID 31263194 DOI: 10.1038/S41565-019-0485-Z |
0.417 |
|
| 2018 |
Li T, Wang L, Lin S, Xu X, Liu M, Shen S, Yan Z, Mo R. Rational Design and Bioimaging Applications of Highly Specific "Turn-On" Fluorescent Probe for Hypochlorite. Bioconjugate Chemistry. PMID 30058797 DOI: 10.1021/acs.bioconjchem.8b00430 |
0.301 |
|
| 2018 |
Liu M, Shen S, Wen D, Li M, Li T, Chen X, Gu Z, Mo R. Hierarchical Nanoassemblies-Assisted Combinational Delivery of Cytotoxic Protein and Antibiotic for Effective Cancer Treatment. Nano Letters. PMID 29547698 DOI: 10.1021/Acs.Nanolett.7B04976 |
0.474 |
|
| 2017 |
Huang K, Zhu L, Wang Y, Mo R, Hua Z. Targeted delivery and release of doxorubicin using a pH-responsive and self-assembling copolymer. Journal of Materials Chemistry. B. 5: 6356-6365. PMID 32264452 DOI: 10.1039/c7tb00190h |
0.393 |
|
| 2017 |
Shen S, Liu M, Li T, Lin S, Mo R. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy. Biomaterials Science. PMID 28664207 DOI: 10.1039/c7bm00297a |
0.358 |
|
| 2017 |
Xue J, Zhao Z, Zhang L, Xue L, Shen S, Wen Y, Wei Z, Wang L, Kong L, Sun H, Ping Q, Mo R, Zhang C. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nature Nanotechnology. PMID 28650441 DOI: 10.1038/nnano.2017.54 |
0.306 |
|
| 2017 |
Qu D, Wang L, Liu M, Shen S, Li T, Liu Y, Huang M, Liu C, Chen Y, Mo R. Oral Nanomedicine Based on Multicomponent Microemulsions for Drug-Resistant Breast Cancer Treatment. Biomacromolecules. PMID 28350158 DOI: 10.1021/acs.biomac.7b00011 |
0.358 |
|
| 2016 |
Yang D, Wang T, Su Z, Xue L, Mo R, Zhang C. Reversing Cancer Multidrug Resistance in Xenograft Models via Orchestrating Multiple Actions of Functional Mesoporous Silica Nanoparticles. Acs Applied Materials & Interfaces. PMID 27420116 DOI: 10.1021/acsami.6b04885 |
0.401 |
|
| 2015 |
Assanhou AG, Li W, Zhang L, Xue L, Kong L, Sun H, Mo R, Zhang C. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Biomaterials. 73: 284-295. PMID 26426537 DOI: 10.1016/j.biomaterials.2015.09.022 |
0.364 |
|
| 2015 |
Pacardo DB, Neupane B, Rikard SM, Lu Y, Mo R, Mishra SR, Tracy JB, Wang G, Ligler FS, Gu Z. A dual wavelength-activatable gold nanorod complex for synergistic cancer treatment. Nanoscale. 7: 12096-103. PMID 26122945 DOI: 10.1039/C5Nr01568E |
0.497 |
|
| 2015 |
Mo R, Jiang T, Sun W, Gu Z. ATP-responsive DNA-graphene hybrid nanoaggregates for anticancer drug delivery. Biomaterials. 50: 67-74. PMID 25736497 DOI: 10.1016/J.Biomaterials.2015.01.053 |
0.455 |
|
| 2015 |
Jiang T, Sun W, Zhu Q, Burns NA, Khan SA, Mo R, Gu Z. Furin-mediated sequential delivery of anticancer cytokine and small-molecule drug shuttled by graphene. Advanced Materials (Deerfield Beach, Fla.). 27: 1021-8. PMID 25504623 DOI: 10.1002/Adma.201404498 |
0.439 |
|
| 2014 |
Sun W, Jiang T, Lu Y, Reiff M, Mo R, Gu Z. Cocoon-like self-degradable DNA nanoclew for anticancer drug delivery. Journal of the American Chemical Society. 136: 14722-5. PMID 25336272 DOI: 10.1021/Ja5088024 |
0.482 |
|
| 2014 |
Lu Y, Mo R, Tai W, Sun W, Pacardo DB, Qian C, Shen Q, Ligler FS, Gu Z. Self-folded redox/acid dual-responsive nanocarriers for anticancer drug delivery. Chemical Communications (Cambridge, England). 50: 15105-8. PMID 25331017 DOI: 10.1039/C4Cc07004F |
0.476 |
|
| 2014 |
Tai W, Mo R, Di J, Subramanian V, Gu X, Buse JB, Gu Z. Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin. Biomacromolecules. 15: 3495-502. PMID 25268758 DOI: 10.1021/Bm500364A |
0.343 |
|
| 2014 |
Mo R, Jiang T, Gu Z. Recent progress in multidrug delivery to cancer cells by liposomes. Nanomedicine (London, England). 9: 1117-20. PMID 25118703 DOI: 10.2217/Nnm.14.62 |
0.458 |
|
| 2014 |
Tai W, Mo R, Lu Y, Jiang T, Gu Z. Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs. Biomaterials. 35: 7194-203. PMID 24875756 DOI: 10.1016/J.Biomaterials.2014.05.004 |
0.493 |
|
| 2014 |
Mo R, Jiang T, Gu Z. Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery. Angewandte Chemie (International Ed. in English). 53: 5815-20. PMID 24764317 DOI: 10.1002/Anie.201400268 |
0.48 |
|
| 2014 |
Mo R, Jiang T, Di J, Tai W, Gu Z. Emerging micro- and nanotechnology based synthetic approaches for insulin delivery. Chemical Society Reviews. 43: 3595-629. PMID 24626293 DOI: 10.1039/C3Cs60436E |
0.348 |
|
| 2014 |
Mo R, Jiang T, DiSanto R, Tai W, Gu Z. ATP-triggered anticancer drug delivery. Nature Communications. 5: 3364. PMID 24618921 DOI: 10.1038/Ncomms4364 |
0.493 |
|
| Show low-probability matches. |